| Headquarters: |
Cambridge |
| Sector: |
Biotechnology |
| Symbol / Exchange: |
BIIB / Nasdaq |
| Employees: |
4,300 |
RANK 19/100 |
| Chief executive: |
James C. Mullen |
| Market value: |
$18.37 billion |
RANK 5/100 |
| 2007 revenue: |
$3.17 billion |
RANK 11/100 |
| 2007 net income: |
$637.2 million |
RANK 8/100 |
| On the net: |
biogenidec.com |
|
|